Researchers presented a regimen-specific synthesis of treatment-related adverse events linked to BRAF and MEK inhibitors.

Teddi Mellencamp has shared a sobering update on her health. On April 2, The Real Housewives of Beverly Hills alum said in an emotional Instagram video that she now has stage IV cancer. Mellencamp was ...

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune ...

The Food and Drug Administration announced on Friday that it had approved the use of a new cancer therapy that researchers say is a groundbreaking way to treat a majority of aggressive and advanced ...

More than half of melanoma patients whose cancer initially responds to immunotherapy will eventually see their disease return ...

Depending on the disease specifics, patients with melanoma may undergo pre- or post-surgical therapies. Skin melanoma, one of the most serious forms of skin cancer, poses a significant threat to ...

University of Cincinnati reported positive Phase 2 melanoma trial results, with a third of patients responding to a combined oncolytic virus and immunotherapy treatment.

Immune therapy is generally safer than chemotherapy, allowing more patients with melanoma and other conditions like heart or lung issues receive treatment. Immune therapy is generally better tolerated ...

The novel Tumor Profiler (TuPro) project, which analyzed melanoma samples using nine independent technologies, demonstrated feasibility in guiding treatment decisions. Molecular tumor board ...